GlassScriptPhysician profile
Nadia P Blanchet
NPI 1851402515
$3,810.38
in general payments reported to CMS, 2019-2025
12 companies · $61.59 in 2025
The $61.59 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,421 · 2020: $748 · 2021: $98.73 · 2022: $302 · 2023: $50.40 · 2024: $130 · 2025: $61.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214 · Education: $27.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.61 |
| Education | $27.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,003.73 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,142.54 | 2019-2023 | |
| Mentor Worldwide LLC | $257.26 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $132.26 | 2019 | |
| Revance Therapeutics, INC. | $62.42 | 2024 | Daxxify |
| Abbvie INC. | $48.73 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $38.21 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.73 | 2019-2020 | |
| Becton, Dickinson and Company | $27.95 | 2024 | |
| Sientra, INC. | $24.87 | 2022 | |
| Acell, INC. | $22.06 | 2019 | |
| Kci USA, INC. | $19.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Blanchet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.